TW202330933A - 用於癌症分類之汙染片段之樣品汙染偵測 - Google Patents

用於癌症分類之汙染片段之樣品汙染偵測 Download PDF

Info

Publication number
TW202330933A
TW202330933A TW111144836A TW111144836A TW202330933A TW 202330933 A TW202330933 A TW 202330933A TW 111144836 A TW111144836 A TW 111144836A TW 111144836 A TW111144836 A TW 111144836A TW 202330933 A TW202330933 A TW 202330933A
Authority
TW
Taiwan
Prior art keywords
cancer
contamination
sites
contaminating
fragments
Prior art date
Application number
TW111144836A
Other languages
English (en)
Chinese (zh)
Inventor
山繆 S 古羅斯
席德哈薩 巴葛里亞
Original Assignee
美商格瑞爾有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商格瑞爾有限責任公司 filed Critical 美商格瑞爾有限責任公司
Publication of TW202330933A publication Critical patent/TW202330933A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/125Bisulfite(s)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/164Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7023(Hyper)proliferation
    • G01N2800/7028Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Primary Health Care (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TW111144836A 2021-11-23 2022-11-23 用於癌症分類之汙染片段之樣品汙染偵測 TW202330933A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163282509P 2021-11-23 2021-11-23
US63/282,509 2021-11-23

Publications (1)

Publication Number Publication Date
TW202330933A true TW202330933A (zh) 2023-08-01

Family

ID=84830091

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111144836A TW202330933A (zh) 2021-11-23 2022-11-23 用於癌症分類之汙染片段之樣品汙染偵測

Country Status (10)

Country Link
US (1) US20230272477A1 (enExample)
EP (1) EP4437130A1 (enExample)
JP (1) JP2024544597A (enExample)
KR (1) KR20240103061A (enExample)
CN (1) CN118591638A (enExample)
AU (1) AU2022398491A1 (enExample)
CA (1) CA3237953A1 (enExample)
IL (1) IL312808A (enExample)
TW (1) TW202330933A (enExample)
WO (1) WO2023097278A1 (enExample)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3765637A1 (en) * 2018-03-13 2021-01-20 Grail, Inc. Anomalous fragment detection and classification
FI3625368T3 (fi) * 2018-08-08 2023-01-13 Menetelmiä john cunningham -viruksen aiheuttaman progressiivin multifokaalin leukoenkefalopatian kehittymisen riskin arviointiin geneettisellä testauksella
WO2020132572A1 (en) * 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
CN119380810A (zh) * 2019-05-13 2025-01-28 格瑞尔有限责任公司 基于模型的特征化和分类
CN115461472A (zh) * 2020-03-30 2022-12-09 格里尔公司 使用合成添加训练样品进行癌症分类
JP2023520889A (ja) * 2020-03-31 2023-05-22 グレイル エルエルシー ゲノム領域モデリングによるがん分類
EP4413581A4 (en) * 2021-10-08 2025-11-05 Found Medicine Inc METHODS AND SYSTEMS FOR DETECTING AND ELIMINATING CONTAMINATION FOR A COPY NUMBER ALTERATION CALL

Also Published As

Publication number Publication date
IL312808A (en) 2024-07-01
KR20240103061A (ko) 2024-07-03
WO2023097278A1 (en) 2023-06-01
CN118591638A (zh) 2024-09-03
CA3237953A1 (en) 2023-06-01
JP2024544597A (ja) 2024-12-03
AU2022398491A1 (en) 2024-06-06
EP4437130A1 (en) 2024-10-02
US20230272477A1 (en) 2023-08-31

Similar Documents

Publication Publication Date Title
JP7498793B2 (ja) 合成トレーニングサンプルによるがん分類
CN116583904A (zh) 用于癌症分类的样品确认
US20240170099A1 (en) Methylation-based age prediction as feature for cancer classification
US20240412821A1 (en) Methylation-based biological sex prediction
US20240312561A1 (en) Optimization of sequencing panel assignments
US20240055073A1 (en) Sample contamination detection of contaminated fragments with cpg-snp contamination markers
KR20250154498A (ko) 백혈구 오염 검출
US20230272477A1 (en) Sample contamination detection of contaminated fragments for cancer classification
US20240233872A9 (en) Component mixture model for tissue identification in dna samples
WO2026015665A1 (en) Determining methylation status of biological samples
WO2024192076A1 (en) Sample barcode in multiplex sample sequencing
KR20250161569A (ko) 혼합 모델에 의한 분류를 위한 테스트 샘플로부터 무세포 dna의 삭제